(Q46311550)

21 December 2017

title

Glaucoma as a neuropathy amenable to neuroprotection and immune manipulation (English)

1 reference

21 December 2017

1

Michal Schwartz

1 reference

21 December 2017

author name string

Anat London

series ordinal

2

1 reference

21 December 2017

language of work or name

1 reference

1 January 2008

1 reference

21 December 2017

Progress in Brain Research

published in

1 reference

21 December 2017

volume

173

1 reference

21 December 2017

page(s)

375-384

1 reference

21 December 2017

Induction of nitrotyrosine-like immunoreactivity in the lower motor neuron of amyotrophic lateral sclerosis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Oxidative stress in neurodegeneration: cause or consequence?

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Vaccination with autoantigen protects against aggregated beta-amyloid and glutamate toxicity by controlling microglia: effect of CD4+CD25+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Antigenic specificity of immunoprotective therapeutic vaccination for glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

T-cell-based vaccination for morphological and functional neuroprotection in a rat model of chronically elevated intraocular pressure.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Autoreactive T cells induce neurotrophin production by immune and neural cells in injured rat optic nerve: implications for protective autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

The effects of ifenprodil and eliprodil on voltage-dependent Ca2+ channels and in gerbil global cerebral ischaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Excitotoxicity and nitric oxide in Parkinson's disease pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

ALS, SOD and peroxynitrite

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Effect of glatiramer acetate on primary and secondary degeneration of retinal ganglion cells in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Delayed functional loss in glaucoma. LII Edward Jackson Memorial Lecture

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

The optic nerve head as a biomechanical structure: a new paradigm for understanding the role of IOP-related stress and strain in the pathophysiology of glaucomatous optic nerve head damage

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Morphological aspects of spinal cord autoimmune neuroprotection: colocalization of T cells with B7--2 (CD86) and prevention of cyst formation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Activation of microglia by aggregated beta-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-gamma and IL-4 render them protective.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Proteomic identification of nitrated proteins in Alzheimer's disease brain

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

The relationship between intraocular pressure and visual field progression in glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Pharmacological neuroprotection for glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Glutamate neurotoxicity and diseases of the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Vaccination for neuroprotection in the mouse optic nerve: implications for optic neuropathies.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Glaucoma as a neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Beyond intraocular pressure: neuroprotective strategies for future glaucoma therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Posttraumatic therapeutic vaccination with modified myelin self-antigen prevents complete paralysis while avoiding autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

The benefit of early trabeculectomy versus conventional management in primary open angle glaucoma relative to severity of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

The use of cyclodialysis to limit exposure to elevated intraocular pressure in rat glaucoma models

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Dopamine, through the extracellular signal-regulated kinase pathway, downregulates CD4+CD25+ regulatory T-cell activity: implications for neurodegeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Neuroprotective autoimmunity: naturally occurring CD4+CD25+ regulatory T cells suppress the ability to withstand injury to the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Free radical scavenging and inhibition of nitric oxide synthase potentiates the neurotrophic effects of brain-derived neurotrophic factor on axotomized retinal ganglion cells In vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Glutamate toxicity in chronic neurodegenerative disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

A century-old debate on protein aggregation and neurodegeneration enters the clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Pathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Excitatory amino acids as a final common pathway for neurologic disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Effects of ocular injury and administration of brain-derived neurotrophic factor on survival and regrowth of axotomized retinal ganglion cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Cellular response to oxidative stress: signaling for suicide and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

The tissue-specific self-pathogen is the protective self-antigen: the case of uveitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Production of neurotrophins by activated T cells: implications for neuroprotective autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Is there more to glaucoma treatment than lowering IOP?

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Reduced glutamate uptake by retinal glial cells under ischemic/hypoxic conditions.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Surgical lowering of elevated intraocular pressure in monkeys prevents progression of glaucomatous disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Outcomes of trabeculectomy for primary open-angle glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Glutaate-induced retinal degeneration in neonatal mice. Electron microscopy of the acutely evolving lesion

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

The role of specific ions in glutamate neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Checkpoints of dueling dimers foil death wishes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

The role of oxidative stress in the dysregulation of gene expression and protein metabolism in neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Neuronal death in glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

From benefit to damage. Glutamate and advanced glycation end products in Alzheimer brain

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Potential role for Ginkgo biloba extract in the treatment of glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Activation of NMDA receptors protects against glutamate neurotoxicity in the retina: evidence for the involvement of neurotrophins

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Glutamate in the mammalian CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Biostatistical evidence for two distinct chronic open angle glaucoma populations

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Neurodegeneration and neuroprotection in glaucoma: development of a therapeutic neuroprotective vaccine: the Friedenwald lecture

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Lessons for glaucoma from other neurodegenerative diseases: can one treatment suit them all?

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Modulating the immune system: a vaccine for glaucoma?

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Protective autoimmunity: interferon-gamma enables microglia to remove glutamate without evoking inflammatory mediators.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Factors influencing optic nerve head biomechanics

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

N-methyl-D-aspartate-induced neurotoxicity in the adult rat retina

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Protective effects of melatonin in experimental free radical-related ocular diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

In vivo protection against NMDA-induced neurodegeneration by MK-801 and nimodipine: combined therapy and temporal course of protection

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Molecular basis of glutamate toxicity in retinal ganglion cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Protective effects of flunarizine on ischemic injury in the rat retina

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Immunostaining of heat shock proteins in the retina and optic nerve head of normal and glaucomatous eyes.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Glial modulation of retinal ganglion cell death in glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Hypoxia-inducible factor 1alpha in the glaucomatous retina and optic nerve head

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Proteomic identification of oxidatively modified retinal proteins in a chronic pressure-induced rat model of glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Caspases: key mediators of apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Caspases: enemies within

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Trafficking of molecules and metabolic signals in the retina

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Primary open-angle glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Targeting protein aggregation in neurodegeneration--lessons from polyglutamine disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

Protective autoimmunity is a physiological response to CNS trauma.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901126-6

7 January 2021

10.1016/S0079-6123(08)01126-6

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017